Literature DB >> 9379033

Recombining sequence recombination in normal kappa-chain-expressing B cells.

O Dunda1, D Corcos.   

Abstract

Recombining sequence (RS) recombination is a DNA rearrangement that deletes one or two C kappa alleles in a large proportion of lambda-expressing B cells. Since its discovery, this recombination has been suggested to play a role in activating lambda gene rearrangements. A model involving a positive signal generated by RS recombination seems to be excluded, but another model that is still under consideration proposes that RS recombination removes DNA sequences within the kappa locus that would interfere with lambda gene assembly. Using PCR assays, we have found that kappa-expressing cells account for the majority of RS rearrangements in mouse spleen. RS rearrangements were also detected by Southern blot in kappa-secreting hybridomas. Quantification of rearrangements indicates that approximately 12% of kappa cells bear an RS recombination. From this finding, we infer that once a cell has performed an RS recombination on one kappa allele, it has a 3 times higher probability of rearranging functionally its other kappa allele rather than one of the lambda genes. These data call into question the role of RS recombination in the switch from kappa to lambda and suggest another function for this nonproductive rearrangement.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9379033

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Role of B cell antigen receptor in regulation of V(D)J recombination and cell survival.

Authors:  D Nemazee
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 2.  Receptor selection in B and T lymphocytes.

Authors:  D Nemazee
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

3.  Skewed primary Igκ repertoire and V-J joining in C57BL/6 mice: implications for recombination accessibility and receptor editing.

Authors:  Miyo Aoki-Ota; Ali Torkamani; Takayuki Ota; Nicholas Schork; David Nemazee
Journal:  J Immunol       Date:  2012-01-27       Impact factor: 5.422

4.  Analysis of expressed and non-expressed IGK locus rearrangements in chronic lymphocytic leukemia.

Authors:  Chrysoula Belessi; Kostas Stamatopoulos; Anastasia Hadzidimitriou; Katerina Hatzi; Tatjana Smilevska; Niki Stavroyianni; Fotini Marantidou; George Paterakis; Athanasios Fassas; Achilles Anagnostopoulos; Nikolaos Laoutaris
Journal:  Mol Med       Date:  2005 Jan-Dec       Impact factor: 6.354

Review 5.  B cell receptor editing in tolerance and autoimmunity.

Authors:  Eline T Luning Prak; Marc Monestier; Robert A Eisenberg
Journal:  Ann N Y Acad Sci       Date:  2011-01-05       Impact factor: 5.691

6.  Rearrangement of mouse immunoglobulin kappa deleting element recombining sequence promotes immune tolerance and lambda B cell production.

Authors:  José Luis Vela; Djemel Aït-Azzouzene; Bao Hoa Duong; Takayuki Ota; David Nemazee
Journal:  Immunity       Date:  2008-02-07       Impact factor: 31.745

7.  An immunoglobulin C kappa-reactive single chain antibody fusion protein induces tolerance through receptor editing in a normal polyclonal immune system.

Authors:  Djemel Ait-Azzouzene; Laurent Verkoczy; Jorieke Peters; Amanda Gavin; Patrick Skog; José Luis Vela; David Nemazee
Journal:  J Exp Med       Date:  2005-02-28       Impact factor: 14.307

8.  Immunoglobulin light chain (IgL) genes in zebrafish: Genomic configurations and inversional rearrangements between (V(L)-J(L)-C(L)) gene clusters.

Authors:  Anastasia M Zimmerman; Gene Yeo; Kerstin Howe; Benjamin J Maddox; Lisa A Steiner
Journal:  Dev Comp Immunol       Date:  2007-09-20       Impact factor: 3.636

9.  RS rearrangement frequency as a marker of receptor editing in lupus and type 1 diabetes.

Authors:  Anil K Panigrahi; Noah G Goodman; Robert A Eisenberg; Michael R Rickels; Ali Naji; Eline T Luning Prak
Journal:  J Exp Med       Date:  2008-12-15       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.